(Italiano) COMUNICAZIONE AI SENSI DELL’ART. 17 DEL REGOLAMENTO EMITTENTI AIM ITALIA

Related News

• PharmaNutra consolidated interim report on...

  PharmaNutra S.p.A. informs that the Board of Directors has examined and approved the consolidated interim...

• Further Analysis of PharmaNutra in Market...

  Market Insight continues its in-depth study of PharmaNutra S.p.A. through interviews with Chairman and...

Related Products

• CardioSiderAL

  CardioSideral® is a nutritional supplement that contains Sucrosomial® Iron (Sideral r.m®), vitamin...

• Novomega

  Nutritional supplement containing EPA and DHA aimed at treating alimentary deficiency or as a complement...